Sheldon Garrison
Geen lopende functies
Profiel
Sheldon Garrison worked as a Director for Pediatric & Rare Diseases at Promentis Pharmaceuticals, Inc. and as a Marketing Specialist at DNASTAR, Inc. He obtained an undergraduate and doctorate degree from the University of Wisconsin.
Eerdere bekende functies van Sheldon Garrison
| Bedrijven | Functie | Einde |
|---|---|---|
DNASTAR, Inc.
 DNASTAR, Inc. Packaged SoftwareTechnology Services DNASTAR, Inc. is a bioinformatics software company that has been innovating since 1984. The private company is based in Madison, WI. The company's flagship product, Lasergene, provides a comprehensive software solution for life science researchers. | Corporate Officer/Principal | - |
Promentis Pharmaceuticals, Inc.
 Promentis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Promentis Pharmaceuticals, Inc. engages in the develop of novel compounds for the treatment of schizophrenia and other central nervous system disorders. The firm's drug development efforts are focused on the neurotransmitter glutamate and its critical role in the pathophysiology of schizophrenia and other disesses. It discovers, develops and markets new drugs for the treatment of important human diseases, focusing initially on developing a new antipsychotic drug to treat schizophrenia. The company was founded by David A. Baker and John Mantsch in 2007 and is headquartered in Milwaukee, WI. | Corporate Officer/Principal | - |
Opleiding van Sheldon Garrison
| University of Wisconsin | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Promentis Pharmaceuticals, Inc.
Promentis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Promentis Pharmaceuticals, Inc. engages in the develop of novel compounds for the treatment of schizophrenia and other central nervous system disorders. The firm's drug development efforts are focused on the neurotransmitter glutamate and its critical role in the pathophysiology of schizophrenia and other disesses. It discovers, develops and markets new drugs for the treatment of important human diseases, focusing initially on developing a new antipsychotic drug to treat schizophrenia. The company was founded by David A. Baker and John Mantsch in 2007 and is headquartered in Milwaukee, WI. | Health Technology |
DNASTAR, Inc.
DNASTAR, Inc. Packaged SoftwareTechnology Services DNASTAR, Inc. is a bioinformatics software company that has been innovating since 1984. The private company is based in Madison, WI. The company's flagship product, Lasergene, provides a comprehensive software solution for life science researchers. | Technology Services |
